AAAAAA

   
Results: 1-11 |
Results: 11
Metalloproteinases in biology and pathology of the nervous system
Authors: Yong, VW Power, C Forsyth, P Edwards, DR
Citation: Vw. Yong et al., Metalloproteinases in biology and pathology of the nervous system, NAT REV NEU, 2(7), 2001, pp. 502-511
Heritable bone disease and stroke due to vertebral artery dissection
Authors: Hill, MD Czechowsky, D Forsyth, P Perry, JR
Citation: Md. Hill et al., Heritable bone disease and stroke due to vertebral artery dissection, CEREB DIS, 12(1), 2001, pp. 73-74
Promoting trade in airline services
Authors: Forsyth, P
Citation: P. Forsyth, Promoting trade in airline services, J AIR TRANS, 7(1), 2001, pp. 43-50
Myeloablative chemotherapy for recurrent aggressive oligodendroglioma
Authors: Cairncross, G Swinnen, L Bayer, R Rosenfeld, S Salzman, D Paleologos, N Kaminer, L Forsyth, P Stewart, D Peterson, K Hu, W Macdonald, D Ramsay, D Smith, A
Citation: G. Cairncross et al., Myeloablative chemotherapy for recurrent aggressive oligodendroglioma, NEURO-ONCOL, 2(2), 2000, pp. 114-119
NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94)
Authors: Gertler, SZ MacDonald, D Goodyear, M Forsyth, P Stewart, DJ Belanger, K Perry, J Fulton, D Steward, W Wainman, N Seymour, L
Citation: Sz. Gertler et al., NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94), ANN ONCOL, 11(3), 2000, pp. 315-318
The price competitiveness of travel and tourism: a comparison of 19 destinations
Authors: Dwyer, L Forsyth, P Rao, P
Citation: L. Dwyer et al., The price competitiveness of travel and tourism: a comparison of 19 destinations, TOUR MANAGE, 21(1), 2000, pp. 9-22
Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340
Authors: Price, A Shi, QA Morris, D Wilcox, ME Brasher, PMA Rewcastle, NB Shalinsky, D Zou, H Appelt, K Johnston, RN Yong, VW Edwards, D Forsyth, P
Citation: A. Price et al., Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340, CLIN CANC R, 5(4), 1999, pp. 845-854
Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells
Authors: Frolichsthal-Schoeller, P Vescovi, AL Krekoski, CA Murphy, G Edwards, DR Forsyth, P
Citation: P. Frolichsthal-schoeller et al., Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells, NEUROREPORT, 10(2), 1999, pp. 345-351
Suppression of ING1 expression in sporadic breast cancer
Authors: Toyama, T Iwase, H Watson, P Muzik, H Saettler, E Magliocco, A DiFrancesco, L Forsyth, P Garkavtsev, I Kobayashi, S Riabowol, K
Citation: T. Toyama et al., Suppression of ING1 expression in sporadic breast cancer, ONCOGENE, 18(37), 1999, pp. 5187-5193
Which glioblastoma multiforme patient will become a long-term survivor? A population-based study
Authors: Scott, JN Rewcastle, NB Brasher, PMA Fulton, D MacKinnon, JA Hamilton, M Cairncross, JG Forsyth, P
Citation: Jn. Scott et al., Which glioblastoma multiforme patient will become a long-term survivor? A population-based study, ANN NEUROL, 46(2), 1999, pp. 183-188
Alternative therapy use in neurologic diseases - Use in brain tumor patients
Authors: Verhoef, MJ Hagen, N Pelletier, G Forsyth, P
Citation: Mj. Verhoef et al., Alternative therapy use in neurologic diseases - Use in brain tumor patients, NEUROLOGY, 52(3), 1999, pp. 617-622
Risultati: 1-11 |